"Dexmedetomidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A imidazole derivative that is an agonist of ADRENERGIC ALPHA-2 RECEPTORS. It is closely-related to MEDETOMIDINE, which is the racemic form of this compound.
| Descriptor ID |
D020927
|
| MeSH Number(s) |
D03.383.129.308.245
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dexmedetomidine".
Below are MeSH descriptors whose meaning is more specific than "Dexmedetomidine".
This graph shows the total number of publications written about "Dexmedetomidine" by people in this website by year, and whether "Dexmedetomidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dexmedetomidine" by people in Profiles.
-
Hagan L, David EM, Horton AR, Marx JO. Effects of Midazolam/Dexmedetomidine with Buprenorphine or Extended-release Buprenorphine Anesthesia in C57BL/6 Mice. J Am Assoc Lab Anim Sci. 2024 03 01; 63(2):172-181.
-
Citrome L, Preskorn SH, Lauriello J, Krystal JH, Kakar R, Finman J, De Vivo M, Yocca FD, Risinger R, Rajachandran L. Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial. J Clin Psychiatry. 2022 10 03; 83(6).
-
Peng K, McIlroy DR, Bollen BA, Billings FT, Zarbock A, Popescu WM, Fox AA, Shore-Lesserson L, Zhou S, Geube MA, Ji F, Bhatia M, Schwann NM, Shaw AD, Liu H. Society of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery. Anesth Analg. 2022 10 01; 135(4):744-756.
-
Shane SE, Langston VC, Wills RW, Denney WS, Knych H, Fontenot RL, Meyer RE, Natalini CC. Pharmacokinetics and pharmacodynamics of intravenous continuous rate infusion and repeated intramuscular administration of dexmedetomidine in standing horses. J Vet Pharmacol Ther. 2021 Jul; 44(4):533-543.
-
Morita Y, Kinoshita H. Incomplete clinical evaluation regarding protective effects of dexmedetomidine on stress and inflammatory responses. Minerva Anestesiol. 2020 02; 86(2):221-222.
-
Singh PM, Panwar R, Borle A, Mulier JP, Sinha A, Goudra B. Perioperative analgesic profile of dexmedetomidine infusions in morbidly obese undergoing bariatric surgery: a meta-analysis and trial sequential analysis. Surg Obes Relat Dis. 2017 Aug; 13(8):1434-1446.
-
Goudra BG, Singh PM, Borle A, Farid N, Harris K. Anesthesia for Advanced Bronchoscopic Procedures: State-of-the-Art Review. Lung. 2015 Aug; 193(4):453-65.
-
Jones JS, Cotugno RE, Singhal NR, Soares N, Semenova J, Nebar S, Parke EJ, Shrader MW, Hotz J. Evaluation of dexmedetomidine and postoperative pain management in patients with adolescent idiopathic scoliosis: conclusions based on a retrospective study at a tertiary pediatric hospital. Pediatr Crit Care Med. 2014 Jul; 15(6):e247-52.